GM1 gangliosidosis type 1

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:79255OMIM:230500E75.1
Who is this for?
Show terms as
4Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Clinical phenotype terms— hover any for plain English:

Broad metacarpalsHP:0001230Decreased beta-galactosidase activityHP:0008166Urinary glycosaminoglycan excretionHP:0003541
Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Mar 2021First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis

Dr. Anupam Sehgal — PHASE1

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for GM1 gangliosidosis type 1.

View clinical trials →

No actively recruiting trials found for GM1 gangliosidosis type 1 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the GM1 gangliosidosis type 1 community →

Specialists

4 foundView all specialists →
CM
Cynthia J Tifft, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 2 active trials
AM
Anupam Sehgal, MBBS
Kingston, Ontario
Specialist

Rare Disease Specialist

PI on 1 active trial
CP
Can Ficicioglu, MD, PhD
PHILADELPHIA, PA
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to GM1 gangliosidosis type 1.

Search all travel grants →NORD Financial Assistance ↗

Community

Open GM1 gangliosidosis type 1Forum →

No community posts yet. Be the first to share your experience with GM1 gangliosidosis type 1.

Start the conversation →

Latest news about GM1 gangliosidosis type 1

Disease timeline:

New trial: First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis

Phase PHASE1 trial recruiting. TSHA-101

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about GM1 gangliosidosis type 1

Which specialists treat GM1 gangliosidosis type 1?

4 specialists and care centers treating GM1 gangliosidosis type 1 are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.